Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06197724

MCG for Identification of Myocardial Ischemia in Suspected NSTE-ACS Patients

Magnetocardiography as an Innovative Diagnostic Tool for Early and Accurate Identification of Myocardial Ischemia in Suspected NSTE-ACS Patients

Status
Recruiting
Phase
Study type
Observational
Enrollment
14,090 (estimated)
Sponsor
Qilu Hospital of Shandong University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this multi-center observational study is to learn about the effectiveness of magnetocardiography in rapid and accurate identification of ischemia in patients with suspected NSTE-ACS.

Detailed description

Rapid and accurate Identification of ischemia in patients with chest pain suspected of non-ST-elevation-acute coronary syndrome (NSTE-ACS) is of great clinical significance for timely and effective treatment. Magnetocardiography based on spin-exchange relaxation-free (SERF) principle can detect the weak magnetic field generated by the heart sensitively, which do not need ultra-low temperature cooling. Magnetic signal does not decay through the skin and tissues as electricity does, hence magnetocardiogram (MCG) contains more information of diagnostic value of ischemia. The aim of this observational study is to optimize and validate MCG models as a fast and accurate strategy for detecting coronary ischemia, as a shortage of blood supply to myocardium, in patients who suffer from chest pain, and compare to routine diagnostic means.

Conditions

Interventions

TypeNameDescription
DEVICEMagnetocardiographyMagnetocardiography

Timeline

Start date
2024-01-02
Primary completion
2025-12-31
Completion
2026-01-31
First posted
2024-01-09
Last updated
2025-09-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06197724. Inclusion in this directory is not an endorsement.